The US Food and Drug Administration (FDA) has approved an investigational new drug (IND) application from Aclaris Therapeutics, allowing the company to begin a placebo-controlled Phase Ia/Ib study of ...

Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality antibodies that offer exceptional specificity and sensitivity.

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more ...

Additionally, in the framework of a licensing agreement and a collaborative endeavor to support innovative research, Debiopharm and Oncodesign Services will present promising new data illustrating how ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Expresstm Antibody Expression service. This new offering enables biotechnology and ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Express™ Antibody Expression service. This new offering enables biotechnology and ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of ...

Researchers at Northwell Health’s Feinstein Institutes for Medical Research found that obinutuzumab, a therapeutic antibody ...